SEARCH
Rat Anti-Human IL-13
DESCRIPTION
SB126d monoclonal antibody is useful as a detection antibody in a sandwich ELISA for quantifying human IL-13 protein levels. Biotinylated SB126d antibody should be paired with purified JES-35G12 antibody (Cat. No.10124-01, JES10-5A2 (Cat. No.10125-01), or JES10-2E10 (Cat. No.10126-01) as the capture antibody with purified recombinant human IL-13 as the standard.
[Technical Bulletin / References ]
Back to Cytokine Research - Human
Cat. No.
Product Description
Clone
Size
USD Price
Order Qty
15930-01
Rat Anti-Human IL-13-UNLB
SB126d
0.5mg
$280.00
15930-08
Rat Anti-Human IL-13-BIOT
SB126d
0.5 mg
$365.00
FORMAT ABBREVIATIONS:
UNLB
- purified, unlabeled antibody
FITC
- fluorescein isothiocyanate-labeled
TRITC
- tetramethlyrhodamine isothiocyanate
AP
- alkaline phosphatase-labeled
HRP
- horseradish peroxidase-labeled
BGAL
- B-galactosidase-labeled
TXRD
- Texas Red
TM
BIOT
- biotin-labeled
R-PE
- R-phycoerythrin-labeled
R-PE/TXRD
- R-phycoerythrin/Texas Red
TM
APC
- allophycocyanin
CY3
- Cyanine
TM
3-labeled *
SPRD
- SpectralRed
TM
-labeled *
LE/AF
- low endotoxin/azide-free
CY5
- Cyanine
TM
5-labeled *
R-PE/CY5.5
- R-phycoerythrin/Cyanine
TM
5.5-labeled *
R-PE/CY7
- R-phycoerythrin/Cyanine
TM
7-labeled *
APC/CY5.5
- allophycocyanin/Cyanine
TM
5.5-labeled *
APC/CY7
- allophycocyanin/Cyanine
TM
7-labeled *
FLMA
- fluorescein-5-malemide-labeled
SEPH
- sepharose-labeled
BIMA
- biotin-maleimide-labeled
NOTE:
*SpectralRed
TM
(SPRD) is a tandem conjugate of R-phycoerythrin and CY
TM
5. It was developed as a reagent for 3-color flow cytometry on instruments with only 488 nm excitation source. It requires minimal (0-2%) FL2/FL3 compensation.
Products
Ordering
Custom Services
Company
New Products
Request 2013 Catalog
Request Information
Create Account
International Distributors
Payment Methods
Terms and Conditions
Shipping Information
Peptide Synthesis
Polyclonal Antibodies
Monoclonal Antibodies
Conjugation
Immunochemistry
Purfication
Testing
Customer Service
Technical Service
Company Profile